Diabetes
Conference Coverage
First fatty liver guidelines for endocrinology, primary care
Endocrinologists and primary care docs “need to be the ones who are diagnosing and managing [non-alcoholic fatty liver disease] because there just...
Commentary
What is the glycemic risk index and why do we need it?
Dr. Anne Peters discusses the development of the glycemic risk index, a new continuous glucose monitoring measure.
From the Journals
Grit your teeth for a lesser-known complication of diabetes
Tooth loss is a lesser-known potential complication of type 2 diabetes. A large meta-analysis quantifies the risk.
Guidance for Practicing Primary Care
Recommendations for improving federal diabetes programs: How primary care clinicians can help with implementation
Recent advances in diabetes treatments have not been translated quickly into practice, and, when they have been, there have been disparities in...
From the Journals
Screening for diabetes at normal BMIs could cut racial disparities
Diabetes screening for Asian and Black individuals aged 35 and over, even at BMIs that are not considered overweight, would be ‘a good place to...
Practice Alert
USPSTF recommendation roundup
Offer pregnant women behavioral counseling to promote healthy weight gain. Screen for type 2 diabetes and prediabetes in adults ages 35 to 70...
From the Journals
Longer use of proton pump inhibitors tied to diabetes risk
‘Physicians should ... avoid unnecessary prescription of this class of drugs,’ say study authors, but a gastroenterologist argues there isn’t...
Conference Coverage
Vegan diet helps shed pounds but doesn’t dint diabetes
A vegan diet most likely led to weight loss because it is “associated with a reduced calorie intake due to a lower content of fat and higher...
Conference Coverage
Calorie counting and exercise ‘of limited value’ for obesity weight loss
“Our survey results indicate that, while the majority of adults with obesity are actively trying to reduce their weight, using a variety of...
Feature
Topline results for dapagliflozin in HFpEF: DELIVER
AstraZeneca says regulatory submissions will be forthcoming, potentially bringing a second SGLT2 inhibitor in this space, after empagliflozin.
Conference Coverage
New research holds promise for fighting obesity, says expert
A growing understanding of adipose tissue as an endocrine organ responsible for weight control opens avenues for treatment, she says.